TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
1.580
-0.050 (-3.07%)
Nov 3, 2026, 10:17 AM EST - Market open
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $26.75 million as of November 3, 2026. It is the 34,406th most valuable company in the world and the 5,000th biggest in the United States. Its market cap has increased by 160.47% in one year.
Market Cap
26.75M
Enterprise Value
19.02M
1-Year Change
160.47%
Global Rank
Country Rank
#5,000 United States
Category
ChartMarket Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $26.75M, a decrease of -44.12%. That is a compound annual growth rate of -10.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 26.75M | 327.13% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aligos Therapeutics | 29.97M |
| Aardvark Therapeutics | 29.76M |
| ProMIS Neurosciences | 29.68M |
| Metagenomi Therapeutics | 29.48M |
| NextCure | 28.88M |
| Estrella Immunopharma | 27.81M |
| BriaCell Therapeutics | 26.81M |
| BeyondSpring | 26.47M |